Atorvastatin and Clopidogrel HIgh DOse in Stable Patients With Residual High Platelet Activity
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate if high-dose (80mg/day) atorvastatin might exert an
adjunctive anti-platelet effect compared to high-dose clopidogrel (150mg/day) in stable
patients with high on-treatment reactivity according to a point-of-care platelet function
assay.